ArticleInternational journal of molecular sciences2020

A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation.

Antonio Vallarola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.